Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trialsWarren B Sateren, Edward L Trimble, Jeffrey Abrams, et al.The Journal of Clinical Investigation|November 24, 2015
Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in miceElaine Wan, Jeffrey Abrams, Richard L Weinberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Steps and time to process clinical trials at the Cancer Therapy Evaluation ProgramDavid M Dilts, Alan B Sandler, Steven K Cheng, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials NetworkJeffrey Abrams, Barbara Conley, Margaret Mooney, et al.Blood|September 6, 2012
Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantationRégis Peffault de Latour, Rodrigo T Calado, Marc Busson, et al.JCI Insight|April 26, 2019
Heterogeneity of the action potential duration is required for sustained atrial fibrillationUma Mahesh R Avula, Jeffrey Abrams, Alexander Katchman, et al.JCI Insight|September 2, 2020
Fibroblast growth factor homologous factors tune arrhythmogenic late NaV1.5 current in calmodulin binding-deficient channelsJeffrey Abrams, Daniel Roybal, Nourdine Chakouri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 2, 2003
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741Marc L Citron, Donald A Berry, Constance Cirrincione, et al.JAMA Oncology|October 1, 2019
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical TrialJoseph A Sparano, Robert J Gray, Della F Makower, et al.Journal of the National Cancer Institute|September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S Albain, Robert J Gray, Della F Makower, et al.Pageof 3